We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon
Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
<< Its over Pfizers ivermectin cuts death by 90% in hospital covid patients Omcron, PFE, and the political stage have ended the pandemic unless they release a worse bug >>
No big surprise there at all. A proper evaluation of Ivermectine is shown in brief here.
•Statistically significant improvements are seen for mortality, ventilation, ICU admission, hospitalization, recovery, cases, and viral clearance. All remain significant after exclusions. 47 studies from 43 independent teams in 19 different countries show statistically significant improvements in isolation (36 primary outcome, 33 most serious outcome). •Meta analysis using the most serious outcome shows 66% [53-76%] and 83% [73-89%] improvement for early treatment and prophylaxis, with similar results after exclusion based sensitivity analysis (excluding all GMK/BBC team studies), for primary outcomes, for peer-reviewed studies, and for RCTs. •Results are very robust — in worst case exclusion sensitivity analysis 58 of 70 studies must be excluded to avoid finding statistically significant efficacy. •While many treatments have some level of efficacy, they do not replace vaccines and other measures to avoid infection. Only 26% of ivermectin studies show zero events in the treatment arm. • Multiple treatments are typically used in combination, which may be significantly more effective. •Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all variants. All practical, effective, and safe means should be used, including treatments, as supported by Pfizer [ Pfizer, TrialSiteNews]. Denying the efficacy of treatments increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage.
